Metacrine's Series B Round

Metacrine raised a round of funding on December 07, 2017.

Metacrine is a biotechnology company focused on developing drugs that materially benefit patients with liver, gastrointestinal, and metabolic diseases. Metacrine's lead program for non-alcoholic steat…

Articles about Metacrine's Series B Round: